Why the study?
Does a polymer-free Biolimus-A9-coated stent with 1-month DAPT improve efficacy and safety compared to a bare-metal stent in high bleeding risk patients with acute coronary syndrome undergoing PCI?
Population
659 high bleeding risk patients with acute coronary syndrome undergoing percutaneous coronary intervention
Comparison
Polymer-free Biolimus-A9-coated stent combined… vs Bare-metal stent combined with 1-month dual…
Design
RCT
Follow-up
12 months
Authors
Loading...
Supports BA9-DCS over BMS in high-bleeding-risk ACS; challenges continued BMS use with short DAPT.
Does a polymer-free Biolimus-A9-coated stent with 1-month DAPT improve efficacy and safety compared to a bare-metal stent in high bleeding risk patients with acute coronary syndrome undergoing PCI?
In high bleeding risk patients with ACS, a polymer-free Biolimus-A9-coated stent with 1-month DAPT is superior to a bare-metal stent for both efficacy and safety, suggesting BMS should no longer be recommended for this indication.
Naber et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: